Comparing Efinaconazole Topical vs Lamisil
| Efinaconazole topical | Lamisil (terbinafine) |
|
|---|
| Efinaconazole topical | Lamisil (terbinafine) |
|
|---|---|---|
|
Prescription only
Prescribed for Onychomycosis - Toenail. Efinaconazole topical may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Onychomycosis - Toenail, Tinea Capitis, Cutaneous Candidiasis, Onychomycosis - Fingernail, Tinea Corporis, Tinea Cruris, Tinea Pedis. Lamisil may also be used for purposes not listed... View more |
Related suggestions Onychomycosis, Toenail
|
| More about Efinaconazole topical | More about Lamisil (terbinafine) | |
| Ratings & Reviews | ||
|
Efinaconazole topical has an average rating of 5.7 out of 10 from a total of 230 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 41% reported a negative effect. |
Lamisil has an average rating of 6.8 out of 10 from a total of 139 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 28% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
|
View all Efinaconazole topical side effects |
View all Lamisil side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
Lower cost generic approved | |
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
|
|
| Brand Names | ||
| Jublia | Other terbinafine brands include: Terbinex | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
29.9 hours |
200 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 156 drugs are known to interact with Lamisil:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | ||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||
| First Approval Date | ||
|
June 06, 2014 |
May 10, 1996 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.